AHSG and cardiovascular disorder: In advanced chronic kidney disease (CKD) and cardiovascular disease (CVD), fetuin-A inhibits ectopic and dystrophic calcium deposition [5, 9–13], and in mice, fetuin-A shows cardio- and vasculoprotective properties through reduced calcification [5–7].